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Up to now, controversy still exists regarding the role of secondhand smoking (SHS) in developing cognitive impairment. This
study aimed to evaluate the prevalence of SHS in hospitalized older patients with cognitive deﬁcit, particularly in those with mild
cognitive impairment (MCI). Smoking history was classiﬁed into four groups: never smokers, former-active smokers/no SHS,
active smokers, and secondhand smokers, and cognitive function into three levels: normal cognition (C), MCI, and dementia. A
total of 933 older subjects with diagnoses of MCI (n = 98), dementia (n = 124), or C (n = 711) were enrolled in this cross-
sectional study. As expected, patients with dementia had signiﬁcantly higher frequency of former-active smokers than cognitively
normal. Moreover, patients with MCI showed a signiﬁcantly higher frequency of active and secondhand smokers than patients
with dementia or C. A smoking history is very frequent in older patients with dementia. Patients with MCI had even higher rate
of exposure to active or secondhand smoking.
1.Introduction
Recent data clearly conﬁrm that active smoking in older peo-
ple is a signiﬁcant risk factor for dementia [1–3], including
Alzheimer’s Disease (AD) [4], although the scientiﬁc liter-
ature has reported conﬂicting results about this topic, with
early reports suggesting no signiﬁcant association between
smoking and cognitive impairment [5, 6] or surprisingly
its protective action against dementia [7–9]. There is also
growing evidence that exposure to secondhand smoking
(SHS) in older nonsmokers may be associated with increased
odds of dementia [10], although remains still unclear the
relationship between SHS and the preclinical phase of
dementia, particularly mild cognitive impairment (MCI),
in older patients. MCI is a transitional and heterogeneous
clinical syndrome that lies between normal aging and
early dementia which refers to nondemented, aged persons
with memory or cognitive impairment and no signiﬁcant
disability [11, 12]. In the developed world, the prevalence
of MCI is more than double that of dementia and its rate
of conversion to dementia is greater than that of general
population.
The aim of this study was to evaluate the smoking history
including the prevalence of exposure to SHS in hospitalized
older patients with cognitive deﬁcit, particularly in those
with MCI.
2. Methods
2.1. Participants. The study population included all patients
aged 65 and older consecutively admitted to the geriatric
ward of the “Paradiso” Hospital, Azienda Sanitaria Locale
Bari (ASL BA), Gioia del Colle (Ba), Italy, from January 2010
toJuly2011.Writteninformedconsentwasobtainedfromall
patientsorfromrelativesofcriticallyillordementedpatients
prior to participation in the study.
2.2. Study Evaluation. At admission, a comprehensive geri-
atricassessment(CGA)[13],including basicandinstrumen-
tal activities of daily living (ADLs, IADLs) [14, 15], cumu-
lative illness rating scale comorbidity index (CIRS severity
and CIRS comorbidity) [16], mini-mental state examination
(MMSE) [17], clinical dementia rating scale (CDR) [18],2 The Scientiﬁc World Journal
geriatric depression scale 15-item (GDS-15) [19], and mini-
nutritional assessment (MNA) [20], was performed by the
staﬀ physician at the ward. The smoking history, evaluated
by a structured questionnaire self-reported by patients or
obtained from relatives of critically ill or demented patients,
was classiﬁed into four groups: never smokers, former-
active smokers/no SHS, active smokers, and secondhand
smokers.“Neversmokers”weredeﬁnedasthosewhohadnot
smoked more than 100 cigarettes in their lifetime, “former-
active smokers/no SHS” as those who had stopped smoking
for at least two years at the date of the interview, “active
smokers” as having smoked a total of at least twenty packs
of cigarettes over their lifetime and at least one cigarette
per day in the last year. “Secondhand smokers” were ﬁnally
deﬁned as those who had at least one hour/week exposure
to SHS. SHS among never or former-active smokers was
assessed ascertaining exposure in seven microenvironments:
the respondent’s home, another person’s home, travelling in
a car or another vehicle, workplace, bars, outdoor locations,
and other locations. In each area, was evaluated the total
duration (in hours) of exposure during the past seven days.
The cognitive function was categorized into three
levels—MCI, dementia, or normal cognition (NoCI)—
according to the neuropsychological test score, as detailed
elsewhere [21].
Diagnosis of MCI was made using the following Petersen
criteria [11, 12]: presence of subjective memory loss, prefer-
ably corroborated by an informant; demonstration of a
memory impairment by cognitive testing; preserved general
intellectual functioning as estimated by performance on
a vocabulary test; intact ability to perform activities of
daily living and absence of dementia. Diagnoses of possi-
ble/probable Alzheimer’s disease (AD), vascular dementia
(VaD), and mixed dementia (MD) were made according
to the criteria of the National Institute of Neurologi-
cal and Communicative Disorders and Stroke/Alzheimer’s
Disease and Related Disorders Association Work Group
[22], the National Institute of Neurological Disorders and
Stroke-Association Internationale pour la Recherche et
l’Enseignement en Neurosciences Work Group [23], and the
Diagnostic and Statistical Manual of Mental Disorders—
Fourth Edition (DSM-IV) [24].
In agreement with the exclusion criteria for MCI deﬁned
by Levy [25], subjects who had present or past medical or
psychiatric condition or psychoactive substance use that can
cause cerebral dysfunction were excluded from the study
to rule out the possibility of cognitive impairment due to
medical or psychiatric conditions.
2.3. Statistical Analyses. Statistical analysis was performed
using the SPSS V. 11.5 for Windows statistical software
package. Pearson’s χ2 test and Fisher’s exact test were
used to compare frequencies of patients according to their
smoking history. The Kruskal-Wallis test was applied to
comparedemographic,cognitive,functional,andnutritional
characteristics as well as comorbidity of the study samples.
Logistic regression analysis adjusted for age, educational
level, and never smokers was also used to conﬁrm the
association between patients smoking history and cognitive
impairment. The ANOVA post hoc analysis was used for
correction in multiple comparisons. All P values were 2-
tailed, with statistical signiﬁcance indicated by a value of
P<0.05.
3. Results
During the study period, 1128 subjects aged 65 and older
were admitted to the hospital’s geriatric ward and were
screened. In 63 subjects, data were not recorded, and 97
patients were excluded from the study because of a diagnosis
of short-term prognosis tumors (n = 20), blood infections
(n = 18), serious anemia (n = 15), disorders of the thyroid
(n = 13), primary or secondary malignant brain neoplasms
(n = 12), alcohol abuse (n = 10), head trauma (n = 6),
and hydrocephalus (n = 3). Thirty-ﬁve patients refused to
participate in the study. Patients who had stopped smoking
during last two years (n = 36) were also excluded from the
study, but all of them presented one of the several above-
mentioned exclusion criteria or refused to participate in
the study. Thus, the ﬁnal analysis included data from 933
older subjects (394 men, 539 woman, mean age 77.2 ± 6.9,
range 65–102 years): 124 patients with dementia (AD = 37
patients, VaD = 45, MD = 42), 98 patients with MCI, and
711 cognitively normal.
Table 1 shows the mean results of variables, expressed
according to the cognitive levels. Patients with dementia had
signiﬁcantly lower MMSE scores (P<0.001), educational
level (P<0.001), and MNA scores (P<0.05) and higher
CDR scores (P<0.001), mean age (P<0.05), and level
of disability (P<0.0001) than patients with MCI or C.
No signiﬁcant diﬀerences were found in CIRS severity, CIRS
comorbidity, and GDS scores between the three groups.
Moreover, MCI patients had signiﬁcantly lower MMSE and
higher CDR scores (P<0.001) than C, but no signiﬁcant
diﬀerences were found in the level of education, mean age,
level of disability, and MNA scores between the two groups.
Also no signiﬁcant diﬀerences were found among patients
withvariousdementiadiagnoses(i.e.,AD,VaD,orMD)with
regard to the above-mentioned variables.
Table 2 illustrates the distribution of the exposure to
cigarette smoking according to the cognitive levels of the
sample study. As expected, the frequency of never smokers
in the patients without cognitive deﬁcit was signiﬁcantly
higher than that in the patients with dementia and MCI
(P<0.0001;OR =3.9,CI =2.1–8.3).However,thefrequency
of former-active smokers/no SHS in patients with dementia
was signiﬁcantly higher than that in C (P<0.0001; OR =
2.5, CI = 1.1–5.2), but no signiﬁcant diﬀerences were found
between patients with dementia and MCI (P = 0.07; OR =
1.0, CI = 0.5–1.4). Moreover, patients with MCI showed a
signiﬁcantly higher frequency of active smokers that patients
with dementia (P<0.005; OR = 2.3, CI = 1.4–4.5) and
C( P = 0.04; OR = 3.0, CI = 1.4–5.9), but no signiﬁcant
diﬀerences were found between patients with dementia and
C(P = 0.09;OR =1.0,CI =0.5–1.6).Similarly,thefrequency
of the secondhand smokers was signiﬁcantly higher in theThe Scientiﬁc World Journal 3
Table 1: Demographic and clinical characteristics of patients according to the cognitive levels.
Dementia (n = 124) MCI (n = 98) C (n = 711)
Age (years) 81.0 ±6.2
∗‡ 76.9 ± 6.5 75.5 ± 6.9
Gender (female) 83 (69.9%) 65 (66.3%) 391 (54.9%)
Instruction (years) 3.2 ±3.7
†‡ 5.2 ± 4.0 5.6 ± 2.9
Mini mental state examination 16.2 ±5.0
†‡ 24.4 ± 1.5§ 27.0 ± 1.8
Clinical dementia rating scale 1.4 ±1.1
†‡ 0.5§ 0
Activities of daily living 3.5 ±2.0
†‡ 5.1 ± 1.1 5.3 ± 1.0
Instrumental activities of daily living 2.5 ±2.1
†‡ 5.9 ± 2.3 6.2 ± 2.2
Cumulative illness rating scale severity 1.8 ± 0.4 1.6 ± 0.5 1.5 ± 0.7
Cumulative illness rating scale comorbidity 2.5 ± 1.5 2.4 ± 1.7 2.7 ± 1.5
Geriatric depression scale 6.0 ± 4.4 5.1 ± 3.1 5.7 ± 3.0
Mini-nutritional assessment 18.3 ±4.7
∗‡ 20.4 ± 4.0 20.9 ± 3.5
Mean ± standard deviation and frequency (%) are reported. The ANOVA post hoc for multiple comparison analysis conﬁrmed the statistical signiﬁcance of
the P values.
∗Dementia versus MCI P<0.05; †Dementia versus MCI P<0.001; ‡Dementia versus C P<0.001; §MCI versus C P<0.001.
Table 2: Cognitive levels and smoking history.
Dementia (n = 124) MCI (n = 98) C (n = 711) Total (n = 933)
Never smokers 25 (20)
∗† 9( 9 )
‡ 306 (43) 340 (36.5)
Former-active smokers/no SHS 79 (64)∗ 49 (51) 284 (40) 412 (44.5)
Active smokers 5 (4)
† 16 (16)§ 64 (9) 85 (9)
Secondhand smokers 15 (12)
† 24 (24)
‡ 57 (8) 96 (10)
χ2 test
Number of patients and frequency (%) are reported.
∗Dementia versus C P<0.001; †Dementia versus MCI P<0.05; ‡MCI versus C P<0.001; §MCI versus C P<0.05.
patients with MCI than that in the patients with dementia
(P<0.03; OR = 2.7, CI = 1.5–4.4) or C (P<0.0001; OR =
1.9, CI = 1.0–3.5), but no signiﬁcant diﬀerences were found
between patients with dementia and C (P = 0.19; OR = 0.9,
CI = 0.4–1.5). At last, no signiﬁcant diﬀerences were found
in frequencies of never smokers, former-active smokers/no
SHS, active smokers, and secondhand smokers among
patients with various above-mentioned dementia diagnoses.
4. Discussion
Clinical research has recently focused on the identiﬁcation
and characterization of early markers of dementia, in order
to identify patients at high risk and to implement preventive
measures to delay the onset of disease. Currently, there is
an increased interest in modiﬁable risk factors determining
progression to dementia such as cigarette smoking. Several
studies have well demonstrated that active smoking may be
a risk factor for dementia in older people [1–4], although
other studies have shown no signiﬁcant association [5, 6]o r
surprisingly a protective action of cigarette smoking against
dementia [7–9], probably due to the protective eﬀect of
nicotine at least in the short term [26]. However, controversy
still exists particularly concerning the association between
secondhand smoking and the preclinical phase of dementia,
including MCI. The lack of knowledge about this topic
may be due to several reasons, including the diﬃculties in
objectively quantifying exposure to tobacco using large-scale
analysis methods, varying stringency in the diagnostic crite-
riausedinparticularlyinMCI,andthelimitedsamplesizeof
frail older people enrolled in clinical trials. So, in the present
study, we evaluated the relationship between exposure to
cigarette smoking and diﬀerent grades of cognitive impair-
ment, particularly MCI, in a sample of hospitalized older
patients from the Apulia region of southern Italy. Surpris-
ingly, we described an extremely high prevalence of smoking
history in our sample study of hospitalized older patients:
only one-third of these patients were classiﬁed as never
smokers, while remaining of them reported a current or
past history of cigarette smoking. In agreement with recent
studies [1–4] that showed a relationship between cigarette
smokinganddeepcognitiveimpairment,ourdataconﬁrmed
a signiﬁcantly higher percentage of smoking history in
patients with dementia than those without cognitive impair-
ment. However, the major ﬁnding of this study is undoubt-
edly represented by the evidence of signiﬁcantly higher
percentages of active smokers in patients with MCI who
are the ones at higher risk of progression to dementia. This
ﬁnding is also supported by evidence of signiﬁcantly higher
percentages of secondhand smokers in patients with MCI,
and is consistent with data recently reported by Barnes et
al. [10]. This evidence, that according to literature reviewed
is the ﬁrst found in a cohort of older inpatients from
Apulia, is of potential clinical value and might suggest that
cigarettesmokingplaysaroleinthetransitionalprocessfrom
normal cognition to mild cognitive disorders, as recently4 The Scientiﬁc World Journal
reported [27] and therefore that further eﬀorts to ensure
smoking cessation and prevention programs toward older
people are necessary. Longitudinal studies are particularly
needed to further investigate and conﬁrm the exact role of
secondhand smoking in developing cognitive impairment in
nondementedolderpeople,possiblysupportedbyinnovative
methods such as the analysis of salivary concentrations of
cotinine, a metabolite of nicotine recently used as biomarker
for recent exposure to secondhand smoking [28]. In line
with the ﬁndings of Anstey et al. [2], our data also indicated
that the smoking history did not vary in patients with
various dementia diagnoses, that is, AD, VaD, or MD. As
recently shown [29], this study gave indication of a possible
association between dementia and older mean age, greater
functional disability, and lower educational level and nutri-
tional status. Comparing patients with dementia according
to diagnosis, no signiﬁcant diﬀerences were found in mean
age, educational level, depression scores, or level of disability.
5. Limitations
This study has several limitations. First, its cross-sectional
design prevents any conclusion about the chronology and
the causality of the observed relationship between smoking
history and cognitive decline that can be only supposed.
Second, results of our sample study of hospitalized older
patients cannot be extended to general population. Lastly,
the self-report questionnaire used, as previously mentioned,
represents an insuﬃcient method to analyze and objectively
quantify exposure to tobacco.
6. Conclusions
In conclusion, the results of the present study showed a
high prevalence of smoking history in hospitalized elderly
patients with dementia. However, the major ﬁnding in this
population of older people from southern Italy was the
evidence of a higher rate of exposure to active or secondhand
smoking in patients with MCI who had not progressed
to dementia, compared to those with no cognitive decline.
This novel ﬁnding suggested that there may be beneﬁt in
smoking cessation and prevention programs toward older
people particularly in the MCI group. Further intervention
studies including innovative methods that are able to
objectively quantify exposure to tobacco will undoubtedly be
informative in this regard.
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